Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

14 Oct 2020 07:00

RNS Number : 9846B
System1 Group PLC
14 October 2020
 

Press Release

14 October 2020

 

System1 Group PLC (AIM: SYS1)

 ("the Company" or "System1")

 

Trading Update

System1, the marketing services group, issues the following update on trading for the six months to end-September 2020. The Company will announce its interim results on 17 November 2020.

 

Overall, the first half of the current year (H1) saw a marked reduction in sales compared to the prior year, due partly to the impact of Covid-19 on the business of many of our clients. The downturn was particularly pronounced in the US, against a very strong H1 2019/20, while the UK and Asia Pacific produced double-digit revenue growth. Both Turnover and Gross Profit for the half year are expected to be some 25% below the comparable 2019/20 period.

 

The Company is reviewing its office footprint for lease impairment in view of the ongoing Covid-19 pandemic and new ways of working. This review may give rise to an impairment charge, but any such adjustment will be a non-cash charge and will be confirmed at the release of Interim Results.

 

Operating Costs were managed down as part of System1's Covid-19 response, and the business took advantage of some government support schemes, notably in the US and the UK. System1 continued to invest in support of future growth in H1, particularly in product innovation and automation. H1 Operating Costs excluding any impairment charges were some 22% lower than in H1 2019/20.

 

Group Pre-tax Profits (excluding any impairment charges) are expected to be some £0.6m in H1, approximately £0.8m lower than in the comparable period.

 

System1's financial position remains strong. Despite lower profits, period end net cash was £5.1m, compared with £4.1m at end-March 2020. Approximately half of the improvement in H1 was due to receipt of an R&D tax credit related to FY 2018-19, and a similar claim for FY 2019-20 is being prepared.

 

Given continued uncertainty over the medium- and longer-term impact of Covid-19, we are continuing to suspend financial guidance for the time being. No 2020/21 interim dividend will be paid (prior year 1.1p).

 

The Company can be found at www.system1group.com.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges/Andrew Potts

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKNBKKBDBDKD
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.